In vitro analysis demonstrates romidepsin resistance without P-gp overexpression in MCF7 DpVp300 cells, suggesting alternative drug resistance pathways.
Figure S2 contains cell cycle analysis and cytotoxicity data for MCF7 DpVp300 cells showing they are resistant to romidepsin and do not overexpress P-gp
No takes yet. Share an insight, caveat, or question.
Robey et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: